Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Vitasora Health ( (AU:VHL) ).
Vitasora Health Limited has appointed corporate governance specialists Charly Duffy and Shelby Coleman as joint company secretaries, succeeding Justin Mouchacca and Nova Taylor, who have resigned from the roles. The appointments strengthen the company’s compliance and governance capabilities, particularly in relation to ASX Listing Rule obligations, as Vitasora continues to expand its connected-care and remote monitoring operations in the U.S. healthcare market.
The most recent analyst rating on (AU:VHL) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Vitasora Health stock, see the AU:VHL Stock Forecast page.
More about Vitasora Health
Vitasora Health Limited is a Melbourne-headquartered provider of remote healthcare solutions focused on the U.S. digital connected care market, offering remote patient monitoring and chronic care management services. Leveraging cutting-edge technology, dedicated clinical teams, and proprietary devices such as the FDA-approved wheezo wheeze-detection system integrated with its respiri app, the company partners with healthcare organisations to improve outcomes, reduce costs and manage chronic conditions across the continuum of care, with operations spanning Australia and an office in Los Angeles.
Average Trading Volume: 2,315,108
Technical Sentiment Signal: Sell
Current Market Cap: A$44.6M
See more data about VHL stock on TipRanks’ Stock Analysis page.